More: Mendus AB: Mendus AB (publ) Interim Report July – September 2022
More: Mendus AB: Mendus AB (publ) Interim Report July – September 2022
The rest is here: Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2022
Go here to read the rest: Addex Reports Q3 2022 Financial Results and Provides Corporate Update
Read the rest here: Tecan and RevoluGen Enter into Agreement for 96-well Plates for Use in Automated Fire Monkey HMW-DNA Extraction Kits Ideal for Scalable DNA Sequencing
Visit link: Cerevel Therapeutics to Present at Upcoming Investor Conferences
View original post here: Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis
See the original post here: Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Go here to read the rest: Impel Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
See the rest here: Pardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Recent Comments